Last reviewed · How we verify
NCT03394092
Serum Concentration of lgG in Patient With Acute Coronary Syndrome
trial testing Quantitative measurements the changes of IgG glycosylation in Acute Coronary Syndrome in 100 participants. Completed in 1 March 2019.
15 January 2019
Quick facts
| Lead sponsor | The First Affiliated Hospital of Dalian Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 15 January 2018 |
| Primary completion | 15 January 2019 |
| Estimated completion | 1 March 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- Quantitative measurements the changes of IgG glycosylation
Conditions studied
- Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →
Sponsor
The First Affiliated Hospital of Dalian Medical University
Who can join
Adults 18 to 80, any sex, with Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the changes in glycopeptides of serum immunoglobulin G in patients with acute myocardial infarction and the relationships between its change and prognosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03394092
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Coronary Syndrome
Currently open trials in the same condition.
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
- NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
- NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
- NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting
Other The First Affiliated Hospital of Dalian Medical University trials
Trials by the same sponsor.
- NCT07397390 — an Observational Study Evaluting the Effectiveness and Safety of DKutting LL Noval Scoring Balloon Angioplasty for Vesse · enrolling by invitation
- NCT06836999 — Deep Sedation in Catheter Ablation of Atrial Fibrillation · NA · not yet recruiting
- NCT06356701 — Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC · Phase 1 · unknown
- NCT06250842 — Benzodiazepine Impact on Cognitive Function: fNIRs and PET/MRI Study · recruiting
- NCT06056973 — Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03394092 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of Dalian Medical University
- Last refreshed: 19 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03394092.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing